Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPureTech Regulatory News (PRTC)

Share Price Information for PureTech (PRTC)

Share Price is delayed by 15 minutes
Get Live Data
123.80    -0.60 (-0.48%)
Bid:
123.60
Ask:
124.00
Spread: 0.40 (0.324%)
Market Cap: £301.35m
PRTC Live PriceLast checked at - London Stock Exchange

Intraday PureTech Share Chart

Transaction in Own Shares

13 Nov 2023 07:00

RNS Number : 1543T
PureTech Health PLC
13 November 2023
 

13 November 2023

 

PureTech Health plc

 

Transaction in Own Shares

 

PureTech Health PLC (the "Company") announces that it has purchased the following number of its ordinary shares of one pence each through Jefferies International Limited ("Jefferies"), as part of its Share Buyback Programme, details of which were announced on 9 May 2022.

 

Date of purchase:

10 November 2023

Number of ordinary shares purchased:

42,611

Highest price paid per share:

171.40p

Lowest price paid per share:

162.80p

Volume weighted average price paid per share:

164.81p

 

PureTech intends to retain the purchased shares in treasury.

Following the above transaction, the Company will have 16,239,318 ordinary shares in treasury and has 273,228,841 ordinary shares in issue (excluding treasury shares). The total number of voting rights in the Company is therefore 273,228,841 which may be used by shareholders in their calculations to determine if they are required to notify their interest in, or a change to their interest in, PureTech Health plc under the FCA's Disclosure Guidance and Transparency Rules.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) (the Market Abuse Regulation), detailed information about the individual purchases is available below.

 

About PureTech Health

PureTech is a clinical-stage biotherapeutics company dedicated to giving life to new classes of medicine to change the lives of patients with devastating diseases. The Company has created a broad and deep pipeline through its experienced research and development team and its extensive network of scientists, clinicians and industry leaders that is being advanced both internally and through its Founded Entities. PureTech's R&D engine has resulted in the development of 27 therapeutics and therapeutic candidates, including two (Plenity® and EndeavorRx®) that have received both U.S. FDA clearance and European marketing authorization and a third (KarXT) that has been filed for FDA approval. A number of these programs are being advanced by PureTech or its Founded Entities in various indications and stages of clinical development, including registration enabling studies. All of the underlying programs and platforms that resulted in this pipeline of therapeutic candidates were initially identified or discovered and then advanced by the PureTech team through key validation points.

 

For more information, visit www.puretechhealth.com or connect with us on X, formerly known as Twitter, @puretechh.

 

Contact:

PureTech

Investor Relations

IR@puretechhealth.com

Individual Transactions

 

Transaction Date

Transaction Time

Volume

Price (GBp)

Platform

Transaction Reference Number

10/11/2023

08:27:20

210

171.4

AQXE

00377884364TRLO0.1.1

10/11/2023

08:27:20

469

171.4

BATE

00377884365TRLO0.1.1

10/11/2023

08:27:20

97

170.2

TRQX

00377884366TRLO0.1.1

10/11/2023

08:27:20

469

169.6

CHIX

00377884369TRLO0.1.1

10/11/2023

08:27:20

469

171

XLON

00377884367TRLO0.1.1

10/11/2023

08:38:02

469

166.6

XLON

00377886852TRLO0.1.1

10/11/2023

09:06:52

31

167.4

XLON

00377892471TRLO0.1.1

10/11/2023

09:06:52

469

167.4

XLON

00377892473TRLO0.1.1

10/11/2023

09:06:52

438

167.4

XLON

00377892472TRLO0.1.1

10/11/2023

09:39:03

938

165.2

XLON

00377897673TRLO0.1.1

10/11/2023

09:39:04

469

165.2

BATE

00377897679TRLO0.1.1

10/11/2023

09:40:16

291

165.2

CHIX

00377897904TRLO0.1.1

10/11/2023

10:16:41

49

166.2

CHIX

00377905104TRLO0.1.1

10/11/2023

10:35:53

210

166.2

AQXE

00377908534TRLO0.1.1

10/11/2023

10:35:53

420

166.2

CHIX

00377908535TRLO0.1.1

10/11/2023

11:32:52

210

166

AQXE

00377916583TRLO0.1.1

10/11/2023

11:32:52

64

166

CHIX

00377916585TRLO0.1.1

10/11/2023

11:32:52

583

166

CHIX

00377916584TRLO0.1.1

10/11/2023

11:32:52

132

166

CHIX

00377916586TRLO0.1.1

10/11/2023

11:32:57

1488

166.6

XLON

00377916596TRLO0.1.1

10/11/2023

11:32:57

1321

166.6

XLON

00377916597TRLO0.1.1

10/11/2023

11:33:14

1035

165.6

XLON

00377916628TRLO0.1.1

10/11/2023

11:48:14

372

165.6

XLON

00377918999TRLO0.1.1

10/11/2023

11:48:14

27

165.6

XLON

00377919000TRLO0.1.1

10/11/2023

11:48:14

985

165.6

XLON

00377919001TRLO0.1.1

10/11/2023

11:48:14

871

165.6

XLON

00377919002TRLO0.1.1

10/11/2023

11:48:14

936

165.6

XLON

00377919003TRLO0.1.1

10/11/2023

11:48:14

469

165.2

BATE

00377919005TRLO0.1.1

10/11/2023

11:48:14

469

165.2

BATE

00377919004TRLO0.1.1

10/11/2023

11:49:48

97

166

TRQX

00377919247TRLO0.1.1

10/11/2023

11:55:46

22

164.8

TRQX

00377920126TRLO0.1.1

10/11/2023

11:55:46

75

164.8

TRQX

00377920128TRLO0.1.1

10/11/2023

11:55:46

1407

165

XLON

00377920127TRLO0.1.1

10/11/2023

12:15:29

123

165.2

XLON

00377924673TRLO0.1.1

10/11/2023

12:17:04

23

165.2

XLON

00377925190TRLO0.1.1

10/11/2023

12:20:52

559

165.2

XLON

00377926338TRLO0.1.1

10/11/2023

12:27:40

24

164.6

TRQX

00377927982TRLO0.1.1

10/11/2023

12:27:41

73

164.6

TRQX

00377927986TRLO0.1.1

10/11/2023

12:27:41

1407

164.6

XLON

00377927987TRLO0.1.1

10/11/2023

12:28:02

172

164

BATE

00377928080TRLO0.1.1

10/11/2023

12:28:02

158

164

CHIX

00377928081TRLO0.1.1

10/11/2023

12:28:02

116

164

CHIX

00377928082TRLO0.1.1

10/11/2023

12:28:02

515

164

CHIX

00377928083TRLO0.1.1

10/11/2023

12:28:02

17

164

CHIX

00377928084TRLO0.1.1

10/11/2023

12:28:02

297

164

BATE

00377928085TRLO0.1.1

10/11/2023

12:28:48

210

163.6

AQXE

00377928210TRLO0.1.1

10/11/2023

12:28:48

196

163.6

AQXE

00377928209TRLO0.1.1

10/11/2023

12:31:13

291

164

XLON

00377928568TRLO0.1.1

10/11/2023

12:31:13

231

164

XLON

00377928569TRLO0.1.1

10/11/2023

12:41:28

123

164

XLON

00377930529TRLO0.1.1

10/11/2023

12:42:22

580

164

XLON

00377930644TRLO0.1.1

10/11/2023

12:43:34

212

164

XLON

00377930839TRLO0.1.1

10/11/2023

12:58:33

938

163.6

XLON

00377933761TRLO0.1.1

10/11/2023

13:04:03

1141

163

XLON

00377934911TRLO0.1.1

10/11/2023

13:04:04

17

162.8

TRQX

00377934917TRLO0.1.1

10/11/2023

13:12:55

79

162.8

TRQX

00377936203TRLO0.1.1

10/11/2023

13:23:21

183

163

XLON

00377937832TRLO0.1.1

10/11/2023

13:23:21

286

163

XLON

00377937831TRLO0.1.1

10/11/2023

13:34:04

201

163

XLON

00377939578TRLO0.1.1

10/11/2023

14:06:41

67

164.4

CHIX

00377946381TRLO0.1.1

10/11/2023

14:34:47

208

163.8

CHIX

00377956468TRLO0.1.1

10/11/2023

14:35:40

261

163.8

CHIX

00377957225TRLO0.1.1

10/11/2023

14:35:40

64

163.8

CHIX

00377957226TRLO0.1.1

10/11/2023

14:35:40

467

163.8

CHIX

00377957227TRLO0.1.1

10/11/2023

14:35:40

210

163.8

AQXE

00377957229TRLO0.1.1

10/11/2023

14:35:40

1407

163.8

XLON

00377957228TRLO0.1.1

10/11/2023

14:36:04

220

163.6

BATE

00377957819TRLO0.1.1

10/11/2023

14:43:07

200

163.6

BATE

00377964092TRLO0.1.1

10/11/2023

15:02:29

469

165

CHIX

00377972744TRLO0.1.1

10/11/2023

15:02:29

210

164.8

AQXE

00377972746TRLO0.1.1

10/11/2023

15:02:29

469

165

CHIX

00377972745TRLO0.1.1

10/11/2023

15:02:29

1407

164.8

XLON

00377972747TRLO0.1.1

10/11/2023

15:02:29

384

164.4

BATE

00377972749TRLO0.1.1

10/11/2023

15:02:29

73

164.4

BATE

00377972748TRLO0.1.1

10/11/2023

15:02:29

12

164.4

BATE

00377972750TRLO0.1.1

10/11/2023

15:02:29

53

164.4

BATE

00377972751TRLO0.1.1

10/11/2023

15:02:29

57

164.4

BATE

00377972752TRLO0.1.1

10/11/2023

15:03:24

266

164.4

BATE

00377973195TRLO0.1.1

10/11/2023

15:03:24

97

164.2

TRQX

00377973196TRLO0.1.1

10/11/2023

15:11:42

240

164

XLON

00377977775TRLO0.1.1

10/11/2023

15:11:42

201

164

XLON

00377977776TRLO0.1.1

10/11/2023

15:17:45

19

163.8

XLON

00377980192TRLO0.1.1

10/11/2023

15:17:53

98

164

TRQX

00377980233TRLO0.1.1

10/11/2023

15:19:43

200

163.8

XLON

00377981054TRLO0.1.1

10/11/2023

15:27:10

267

163.4

CHIX

00377983978TRLO0.1.1

10/11/2023

15:27:10

542

163.4

CHIX

00377983979TRLO0.1.1

10/11/2023

15:27:10

469

163.4

XLON

00377983980TRLO0.1.1

10/11/2023

15:27:10

210

163.4

AQXE

00377983981TRLO0.1.1

10/11/2023

15:28:28

68

163

XLON

00377984546TRLO0.1.1

10/11/2023

15:31:08

97

164

TRQX

00377985528TRLO0.1.1

10/11/2023

15:32:38

29

163.6

XLON

00377985956TRLO0.1.1

10/11/2023

15:32:56

29

163.6

XLON

00377986163TRLO0.1.1

10/11/2023

15:35:00

446

164.4

BATE

00377986761TRLO0.1.1

10/11/2023

15:51:44

215

163.6

XLON

00377996251TRLO0.1.1

10/11/2023

15:51:44

350

163.6

XLON

00377996250TRLO0.1.1

10/11/2023

15:51:44

56

162.8

BATE

00377996252TRLO0.1.1

10/11/2023

15:51:44

938

162.8

XLON

00377996254TRLO0.1.1

10/11/2023

15:51:44

302

163.6

XLON

00377996253TRLO0.1.1

10/11/2023

15:51:44

97

162.8

TRQX

00377996255TRLO0.1.1

10/11/2023

15:51:44

97

162.8

TRQX

00377996256TRLO0.1.1

10/11/2023

15:53:05

72

163

AQXE

00377997315TRLO0.1.1

10/11/2023

15:58:00

69

163

AQXE

00378000050TRLO0.1.1

10/11/2023

15:58:43

455

163

BATE

00378000314TRLO0.1.1

10/11/2023

15:59:08

190

163

AQXE

00378000482TRLO0.1.1

10/11/2023

15:59:08

69

163

AQXE

00378000481TRLO0.1.1

10/11/2023

15:59:08

14

163

BATE

00378000483TRLO0.1.1

10/11/2023

16:02:15

58

162.8

XLON

00378001890TRLO0.1.1

10/11/2023

16:03:40

1349

162.8

XLON

00378002596TRLO0.1.1

10/11/2023

16:27:40

938

164

XLON

00378021235TRLO0.1.1

10/11/2023

16:29:25

242

163.8

CHIX

00378022177TRLO0.1.1

10/11/2023

16:29:48

937

164

XLON

00378022739TRLO0.1.1

10/11/2023

16:29:49

83

164

XLON

00378022749TRLO0.1.1

10/11/2023

16:29:49

2277

164

XLON

00378022750TRLO0.1.1

10/11/2023

16:29:57

54

164

XLON

00378022910TRLO0.1.1

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSFLFFALDLILIV
Date   Source Headline
9th Jun 20267:00 amRNS-RPRTC's SPTX: New Positive GlyphAgo Ph1 Dosing Data
4th Jun 20265:37 pmRNSHolding(s) in Company
29th May 20265:00 pmRNSHolding(s) in Company
27th May 20265:30 pmRNSHolding(s) in Company
22nd May 20265:00 pmRNSHolding(s) in Company
15th May 20267:00 amRNSCorrection - Holding(s) in Company
13th May 202612:00 pmRNS-RPRTC To Showcase Deupirfenidone at ATS Conference
8th May 20267:00 amRNSHolding(s) in Company
7th May 20266:27 pmRNSHolding(s) in Company
1st May 20267:00 amRNSPureTech's Seaport Prices Upsized IPO Nasdaq: SPTX
29th Apr 20267:01 amRNSFinal Results
29th Apr 20267:00 amRNSPRTC Voluntarily Delists Nasdaq Depositary Shares
27th Apr 20266:09 pmRNSHolding(s) in Company
27th Apr 202612:05 pmRNS-RPRTC's Seaport Adds Neuropsychiatry Veteran to BOD
24th Apr 20265:58 pmRNSHolding(s) in Company
22nd Apr 202612:00 pmRNS-RPRTC's Gallop: Positive Ph1 Topline MDS & AML Data
16th Apr 20265:00 pmRNSHolding(s) in Company
16th Apr 20267:00 amRNSHolding(s) in Company
13th Apr 20267:05 amRNSNotice of Results
13th Apr 20267:00 amRNSPRTC's Seaport Files for Proposed Nasdaq IPO
1st Apr 20267:00 amRNSTotal Voting Rights
25th Mar 20266:00 pmRNS-RPRTC’s Seaport: GlyphAllo Paper Published
13th Mar 20264:35 pmRNSPDMR Notification RSU Vesting
2nd Mar 20267:00 amRNSTotal Voting Rights
25th Feb 20267:00 amRNS-RPRTC to Present at Leerink Healthcare Conference
19th Feb 20265:15 pmRNS-RPRTC's Deupirfenidone Granted FDA & EU ODD for IPF
6th Jan 202612:00 pmRNS-RPureTech to Present at the JP Morgan Conference
18th Dec 20257:00 amRNSPureTech Appoints Robert Lyne as CEO
10th Dec 20255:41 pmRNSResults of AGM on June 16, 2025 – Update Statement
10th Dec 20255:30 pmRNSHolding(s) in Company
8th Dec 20257:00 amRNS-RPRTC: Successful FDA Meeting; IPF Phase 3 in 1H26
5th Dec 20256:00 pmRNS-RPRTC's Gallop: Positive Initial Topline AML Data
18th Nov 20255:30 pmRNSHolding(s) in Company
7th Nov 20256:18 pmRNSHolding(s) in Company
3rd Nov 20252:00 pmRNS-RPRTC: New LYT-200 AML Data + Update at ASH
22nd Oct 20257:00 amRNS-RPRTC: New IPF Data Show Benefit in Older Patients
17th Oct 20255:30 pmRNSHolding(s) in Company
14th Oct 20257:00 amRNSHolding(s) in Company
10th Oct 20255:59 pmRNSHolding(s) in Company
9th Oct 20256:10 pmRNSHolding(s) in Company
1st Oct 20257:00 amRNSHolding(s) in Company
29th Sep 20257:00 amRNS-RPRTC: New IPF Data Show Switch Patients Stabilized
24th Sep 20257:00 amRNSPDMR DEALING - PURCHASE OF SHARES
23rd Sep 20255:30 pmRNSHolding(s) in Company
19th Sep 20255:52 pmRNSHolding(s) in Company
19th Sep 20257:00 amRNSHolding(s) in Company
11th Sep 202512:05 pmRNS-RPRTC's Seaport Advances 2nd Candidate Into Clinic
4th Sep 20255:30 pmRNSHolding(s) in Company
1st Sep 20257:00 amRNSTotal Voting Rights
28th Aug 20257:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.